BIIB104
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB104, covering 2023-04-18 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]